Affiliation
Department of Surgery, National Cancer Institute of Milan, Milan, Italy.Issue Date
2008-09-15
Metadata
Show full item recordAbstract
At the Fifth International Workshop on Peritoneal Surface Malignancy, in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. Five conflicting points were discussed: radicality of the peritonectomy procedure, cytoreduction of neoplastic nodules <2.5 mm, the timing of bowel anastomoses in relation to hyperthermic intraperitoneal chemotherapy (HIPEC) and indications of protective ostomies. According to the panel of experts a partial parietal peritonectomy restricted to the macroscopically involved regions could be indicated in all listed clinical conditions with the exception of peritoneal mesothelioma. No expert was of the opinion that a radical parietal peritonectomy is advisable irrespective of the disease being treated. All the experts agreed that electrovaporization of small (<2.5 mm) non-infiltrating metastatic nodules in the mesentery would be appropriate, even if theoretically the HIPEC affords microscopic cytoreduction. The panel also agreed that in the closed technique for HIPEC administration the intestinal anastomoses should be fashioned after completion of the perfusion. Finally when considering the place for protective ostomies the experts voted for a flexible approach allowing the surgeon to exercise discretion for individual patients.Citation
Technical aspects of cytoreductive surgery. 2008, 98 (4):232-6 J Surg OncolJournal
Journal of Surgical OncologyDOI
10.1002/jso.21058PubMed ID
18726883Type
ArticleLanguage
enISSN
1096-9098ae974a485f413a2113503eed53cd6c53
10.1002/jso.21058
Scopus Count
Related articles
- The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy.
- Authors: Kusamura S, Baratti D, Younan R, Deraco M
- Issue date: 2008 Sep 15
- Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
- Authors: Kusamura S, Dominique E, Baratti D, Younan R, Deraco M
- Issue date: 2008 Sep 15
- The eligibility for local-regional treatment of peritoneal surface malignancy.
- Authors: Verwaal VJ, Kusamura S, Baratti D, Deraco M
- Issue date: 2008 Sep 15
- Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion.
- Authors: Younan R, Kusamura S, Baratti D, Oliva GD, Costanzo P, Favaro M, Gavazzi C, Deraco M
- Issue date: 2005 Nov
- Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
- Authors: Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M
- Issue date: 2007 Oct